CNP infusion attenuates cardiac dysfunction and inflammation in myocarditis

Biochemical and Biophysical Research Communications

Volumn 356, Issue 1, 2007, Pages 60-66

  Obata, Hiroaki ^a,b   Yanagawa, Bobby ^a   Tanaka, Koichi ^a   Ohnishi, Shunsuke ^a   Kataoka, Masaharu ^a   Miyahara, Yoshinori ^a   Ishibashi Ueda, Hatsue ^a   Kodama, Makoto ^b   Aizawa, Yoshifusa ^b   Kangawa, Kenji ^a   Nagaya, Noritoshi ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Angiogenesis; Inflammation; MCP 1; Myocarditis; Natriuretic peptides

Indexed keywords

CD68 ANTIGEN; GUANYLATE CYCLASE; GUANYLATE CYCLASE B; MONOCYTE CHEMOTACTIC PROTEIN 1; MYOSIN; NATRIURETIC PEPTIDE TYPE C; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; CAPILLARY DENSITY; CELL INFILTRATION; CONTINUOUS INFUSION; CONTROLLED STUDY; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMICS; INFLAMMATION; INFLAMMATORY CELL; MALE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE NECROSIS;

ANIMALS; BLOOD PRESSURE; BLOOD VESSELS; CHEMOKINE CCL2; CYCLIC GMP; ENZYME-LINKED IMMUNOSORBENT ASSAY; GUANYLATE CYCLASE; HEART; HEART RATE; INFLAMMATION; MALE; MYOCARDITIS; MYOCARDIUM; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, C-TYPE; RADIOIMMUNOASSAY; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SWINE; VON WILLEBRAND FACTOR;

RATTUS; SUS;

EID: 33947103522     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.02.085     Document Type: Article

References (21)

1. Magnani J.W., and Dec G.W. Myocarditis: current trends in diagnosis and treatment. Circulation 113 (2006) 876-890
2. McNamara D.M., Rosenblum W.D., Janosko K.M., Trost M.K., Villaneuva F.S., Demetris A.J., Murali S., and Feldman A.M. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation 95 (1997) 2476-2478
3. Kuhl U., Pauschinger M., Schwimmbeck P.L., Seeberg B., Lober C., Noutsias M., Poller M., and Schultheiss H.P. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107 (2003) 2793-2798
4. McNamara D.M., Holubkov R., Starling R.C., Dec G.W., Loh E., Torre-Amione G., Gass A., Janosko K., Tokarczyk T., Kessler P., Mann D.L., and Feldman A.M. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 103 (2001) 2254-2259
5. Sudoh T., Minamino N., Kangawa K., and Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem. Biophys. Res. Commun. 168 (1990) 863-870
6. Furuya M., Aisaka K., Miyazaki T., Honbou N., Kawashima K., Ohno T., Tanaka S., Minamino N., Kangawa K., and Matsuo H. C-type natriuretic peptide inhibits intimal thickening after vascular injury. Biochem. Biophys. Res. Commun. 193 (1993) 248-253
7. Horio T., Tokudome T., Maki T., Yoshihara F., Suga S., Nishikimi T., Kojima M., Kawano Y., and Kangawa K. Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts. Endocrinology 144 (2003) 2279-2284
8. Tokudome T., Horio T., Soeki T., Mori K., Kishimoto I., Suga S., Yoshihara F., Kawano Y., Kohno M., and Kangawa K. Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and endothelin-1 signaling pathways. Endocrinology 145 (2004) 2131-2140
9. Soeki T., Kishimoto I., Okumura H., Tokudome T., Horio T., Mori K., and Kangawa K. C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction. J. Am. Coll. Cardiol. 45 (2005) 608-616
10. Kashimura T., Hayashi M., Kodama M., Nakazawa M., Abe S., Yoshida T., Tachikawa H., Hanawa H., Kato K., Watanabe K., and Aizawa Y. Effects of imidapril and TA-606 on rat dilated cardiomyopathy after myocarditis. Jpn. Heart J. 44 (2003) 735-744
11. Kodama M., Matsumoto Y., Fujiwara M., Masani F., Izumi T., and Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin. Immunol. Immunopathol. 57 (1990) 250-262
12. Nunez D.J., Dickson M.C., and Brown M.J. Natriuretic peptide receptor mRNAs in the rat and human heart. J. Clin. Invest. 90 (1992) 1966-1971
13. Kodama M., Hanawa H., Saeki M., Hosono H., Inomata T., Suzuki K., and Shibata A. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ. Res. 75 (1994) 278-284
14. Itoh T., Nagaya N., Murakami S., Fujii T., Iwase T., Ishibashi-Ueda H., Yutani C., Yamagishi M., Kimura H., and Kangawa K. C-type natriuretic peptide ameliorates monocrotaline-induced pulmonary hypertension in rats. Am. J. Respir. Crit. Care Med. 170 (2004) 1204-1211
15. Igaki T., Itoh H., Suga S.I., Hama N., Ogawa Y., Komatsu Y., Yamashita J., Doi K., Chun T.H., and Nakao K. Effects of intravenously administered C-type natriuretic peptide in humans: comparison with atrial natriuretic peptide. Hypertens. Res. 21 (1998) 7-13
16. Ahluwalia A., MacAllister R.J., and Hobbs A.J. Vascular actions of natriuretic peptides. Cyclic GMP-dependent and -independent mechanisms. Basic. Res. Cardiol. 99 (2004) 83-89
17. Osawa H., Yamabe H., Kaizuka M., Tamura N., Tsunoda S., Baba Y., Shirato K., Tateyama F., and Okumura K. C-type natriuretic peptide inhibits proliferation and monocyte chemoattractant protein-1 secretion in cultured human mesangial cells. Nephron 86 (2000) 467-472
18. Murakami S., Nagaya N., Itoh T., Fujii T., Iwase T., Hamada K., Kimura H., and Kangawa K. C-type natriuretic peptide attenuates bleomycin-induced pulmonary fibrosis in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 287 (2004) L1172-L1177
19. Yamahara K., Itoh H., Chun T.H., Ogawa Y., Yamashita J., Sawada N., Fukunaga Y., Sone M., Yurugi-Kobayashi T., Miyashita K., Tsujimoto H., Kook H., Feil R., Garbers D.L., Hofmann F., and Nakao K. Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration. Proc. Natl. Acad. Sci. USA 100 (2003) 3404-3409
20. Dong R., Liu P., Wee L., Butany J., and Sole M.J. Verapamil ameliorates the clinical and pathological course of murine myocarditis. J. Clin. Invest. 90 (1992) 2022-2030
21. Choy J.C., Lui A.H., Moien-Afshari F., Wei K., Yanagawa B., McManus B.M., and Laher I. Coxsackievirus B3 infection compromises endothelial-dependent vasodilation of coronary resistance arteries. J. Cardiovasc. Pharmacol. 43 (2004) 39-47